NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 32 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2021. The put-call ratio across all filers is 1.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $33,000 | -72.3% | 33,467 | -50.6% | 0.00% | – |
| Q3 2021 | $119,000 | -37.0% | 67,779 | -34.4% | 0.00% | – |
| Q2 2021 | $189,000 | -35.3% | 103,321 | -28.6% | 0.00% | -100.0% |
| Q1 2021 | $292,000 | +33.3% | 144,645 | +41.9% | 0.00% | 0.0% |
| Q4 2020 | $219,000 | +24.4% | 101,949 | +56.6% | 0.00% | 0.0% |
| Q3 2020 | $176,000 | -48.8% | 65,089 | -25.5% | 0.00% | -50.0% |
| Q2 2020 | $344,000 | – | 87,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
| Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
| Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
| UBS Group AG | 1,785 | $5,000 | 0.00% |